April 16, 2024NeurologyOpen Access

Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort

View Full Paper

Ask AI

Bookmark

Elevated blood-based biomarkers in Alzheimer disease correlate with accelerated cognitive decline across distinct cognitive domains over follow-up.
Analysis of the MEMENTO cohort tracks cognitive trajectories and functional domains longitudinally over a specified 5-year follow-up period.
Evaluating blood-based biomarkers across specific functional domains highlights opportunities to improve clinical monitoring for Alzheimer disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cohort study observes associations between blood-based biomarkers and accelerated cognitive decline over five years, highlighting domain-specific trajectories.

Cite This Study

Grasset et al. (2024) studied this question.

synapsesocial.com/papers/68e6ee09b6db64358766883c https://doi.org/10.1212/wnl.0000000000209307

View Full Paper

Ask AI

Bookmark

Implication

Cohort study observes associations between blood-based biomarkers and accelerated cognitive decline over five years, highlighting domain-specific trajectories.

Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort

Key Points

Discussion

Implication

Cite This Study

Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider